Clinical Trials Logo

Recurrent/Refractory Secondary Central Nervous System Lymphoma clinical trials

View clinical trials related to Recurrent/Refractory Secondary Central Nervous System Lymphoma.

Filter by:
  • None
  • Page 1

NCT ID: NCT02301364 Completed - Lymphoma Clinical Trials

Buparlisib (BKM120) In Patients With Recurrent/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Recurrent/Refractory Secondary Central Nervous System Lymphoma (SCNSL)

Start date: November 20, 2014
Phase: Phase 2
Study type: Interventional

The purpose of this study is to find out what effects, good and/or bad, Buparlisib (also known as BKM120) has on lymphoma and the central nervous system.